# OnCo record martin-van-den-bent (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/martin-van-den-bent/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "martin-van-den-bent" ;
  schema:name "Martin J. van den Bent"@en ;
  schema:description "Led the EORTC glioma trials that established chemotherapy for anaplastic gliomas and the value of 1p/19q and IDH status."@en ;
  schema:url <https://onco.cc/people/martin-van-den-bent/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=van%20den%20Bent%20MJ%5BAuthor%5D%20glioma> ;
  onco:tag "glioma", "eortc", "chemotherapy" ;
  schema:jobTitle "Professor of Neuro-Oncology, Erasmus MC Cancer Institute" ;
  schema:sameAs <https://orcid.org/0000-0001-5710-5127> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:institutions <https://onco.cc/institutions/erasmus-mc/> ;
  onco:trials <https://onco.cc/trials/eortc-26981/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-stupp-temozolomide-nejm-2005/> ;
  schema:affiliation <https://onco.cc/institutions/erasmus-mc/> .